Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of exenatide on microcirculation in patients with type 2 diabetes mellitus and coronary artery disease
2008-008367-95Phase 4Active
- Sponsor
- Karolinska Institutet
- Start
- Feb 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM) and coronary arteriosclerosis (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Change in microvascular function measured by iontophoresis. Started Feb 2009; status: active.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-008367-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008367-95.